
Journal of Alternative and Complementary Medicine
| PMC full text: | Published online 2020 Oct 8. doi: 10.1089/acm.2020.0181
|
Table 1.
AGREE Global Rating Scale
| Each item is rated on a 1–7 scale from lowest (1) to highest (7) quality; maximum score = 49. Quality assessed as follows: |
| • Divide total score by 7 for average score. |
| • High quality: average 6–7; acceptable quality: average 4–5; unacceptable quality: <4 |
| Process of development |
| 1. Rate the overall quality of the guideline development methods. |
| • Were the appropriate stakeholders involved in the development of the guideline? |
| • Was the evidentiary base developed systematically? |
| • Were recommendations consistent with the literature |
| Presentation style |
| 2. Rate the overall quality of the guideline presentation. |
| • Was the guideline well organized? |
| • Were the recommendations easy to find? |
| Completeness of reporting |
| 3. Rate the completeness of reporting. |
| • Was the guideline development process transparent and reproducible? |
| • How complete was the information to inform decision-making? |
| Clinical validity |
| 4. Rate the overall quality of the guideline recommendations. |
| • Are the recommendations clinically sound? |
| • Are the recommendations appropriate for the intended patients? |
| Overall assessment |
| 5. Rate the overall quality of this guideline. |
| 6. I would recommend this guideline for use in practice. |
| 7. I would make use of a guideline of this quality in my professional decisions. |